Loss of sarcospan exacerbates pathology inmdxmice, but does not affect utrophin amelioration of disease
Open Access
- 11 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 30 (3-4) , 149-159
Abstract
The dystrophin–glycoprotein complex (DGC) is a membrane adhesion complex that provides structural stability at the sarcolemma by linking the myocyte’s internal cytoskeleton and external extracellular matrix. In Duchenne muscular dystrophy (DMD), the absence of dystrophin leads to the loss of the DGC at the sarcolemma, resulting in sarcolemmal instability and progressive muscle damage. Utrophin (UTRN), an autosomal homolog of dystrophin, is upregulated in dystrophic muscle and partially compensates for the loss of dystrophin in muscle from patients with DMD. Here, we examine the interaction between Utr and sarcospan (SSPN), a small transmembrane protein that is a core component of both UTRN–glycoprotein complex (UGC) and DGC. We show that additional loss of SSPN causes an earlier onset of disease in dystrophin-deficient mdx mice by reducing the expression of the UGC at the sarcolemma. In order to further evaluate the role of SSPN in maintaining therapeutic levels of Utr at the sarcolemma, we tested the effect of Utr transgenic overexpression in mdx mice lacking SSPN (mdx:SSPN −/−:Utr-Tg). We found that overexpression of Utr restored SSPN to the sarcolemma in mdx muscle but that the ablation of SSPN in mdx muscle reduced Utr at the membrane. Nevertheless, Utr overexpression reduced central nucleation and improved grip strength in both lines. These findings demonstrate that high levels of Utr transgenic overexpression ameliorate the mdx phenotype independently of SSPN expression but that loss of SSPN may impair Utr-based mechanisms that rely on lower levels of Utr protein.Keywords
Funding Information
- Edith Hyde Fellowship (274143)
- National Institutes of Health (F32 AR069469, T32 AR059033, IRACDA Award K12 GM106996, T32 GM07104, R01 AR048179)
This publication has 57 references indexed in Scilit:
- Sarcospan-dependent Akt activation is required for utrophin expression and muscle regenerationJournal of Cell Biology, 2012
- Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studiesNeuromuscular Disorders, 2012
- Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophinJournal of Cell Science, 2010
- Sarcoglycanopathy: Clinical and histochemical characteristics in 66 patientsNeurology India, 2010
- Sarcospan reduces dystrophic pathology: stabilization of the utrophin–glycoprotein complexJournal of Cell Biology, 2008
- Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophyNeurobiology of Disease, 2008
- Revised spectrum of mutations in sarcoglycanopathiesEuropean Journal of Human Genetics, 2008
- Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan SubcomplexJournal of Cell Biology, 1999
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992
- THE CONTRIBUTION OF I131‐LABELED PROTEINS TO MEASUREMENTS OF BLOOD VOLUMEAnnals of the New York Academy of Sciences, 1957